Literature DB >> 25972456

Gauging heterogeneity in primary versus recurrent glioblastoma.

Simone P Niclou1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25972456      PMCID: PMC5762011          DOI: 10.1093/neuonc/nov078

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  22 in total

Review 1.  Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis.

Authors:  Fabien Kuttler; Sabine Mai
Journal:  Semin Cancer Biol       Date:  2006-10-26       Impact factor: 15.707

2.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

3.  Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.

Authors:  David A Nathanson; Beatrice Gini; Jack Mottahedeh; Koppany Visnyei; Tomoyuki Koga; German Gomez; Ascia Eskin; Kiwook Hwang; Jun Wang; Kenta Masui; Andres Paucar; Huijun Yang; Minori Ohashi; Shaojun Zhu; Jill Wykosky; Rachel Reed; Stanley F Nelson; Timothy F Cloughesy; C David James; P Nagesh Rao; Harley I Kornblum; James R Heath; Webster K Cavenee; Frank B Furnari; Paul S Mischel
Journal:  Science       Date:  2013-12-05       Impact factor: 47.728

4.  Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.

Authors:  Martin J van den Bent; Ya Gao; Melissa Kerkhof; Johan M Kros; Thierry Gorlia; Kitty van Zwieten; Jory Prince; Sjoerd van Duinen; Peter A Sillevis Smitt; Martin Taphoorn; Pim J French
Journal:  Neuro Oncol       Date:  2015-02-16       Impact factor: 12.300

5.  Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.

Authors:  Nicholas J Szerlip; Alicia Pedraza; Debyani Chakravarty; Mohammad Azim; Jeremy McGuire; Yuqiang Fang; Tatsuya Ozawa; Eric C Holland; Jason T Huse; Suresh Jhanwar; Margaret A Leversha; Tom Mikkelsen; Cameron W Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-08       Impact factor: 11.205

6.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Authors:  Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T W Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; Marcel Kool; Marc Zapatka; Natalia Becker; Manuela Zucknick; Thomas Hielscher; Xiao-Yang Liu; Adam M Fontebasso; Marina Ryzhova; Steffen Albrecht; Karine Jacob; Marietta Wolter; Martin Ebinger; Martin U Schuhmann; Timothy van Meter; Michael C Frühwald; Holger Hauch; Arnulf Pekrun; Bernhard Radlwimmer; Tim Niehues; Gregor von Komorowski; Matthias Dürken; Andreas E Kulozik; Jenny Madden; Andrew Donson; Nicholas K Foreman; Rachid Drissi; Maryam Fouladi; Wolfram Scheurlen; Andreas von Deimling; Camelia Monoranu; Wolfgang Roggendorf; Christel Herold-Mende; Andreas Unterberg; Christof M Kramm; Jörg Felsberg; Christian Hartmann; Benedikt Wiestler; Wolfgang Wick; Till Milde; Olaf Witt; Anders M Lindroth; Jeremy Schwartzentruber; Damien Faury; Adam Fleming; Magdalena Zakrzewska; Pawel P Liberski; Krzysztof Zakrzewski; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Sorana Morrissy; Florence Cavalli; Michael D Taylor; Peter van Sluis; Jan Koster; Rogier Versteeg; Richard Volckmann; Tom Mikkelsen; Kenneth Aldape; Guido Reifenberger; V Peter Collins; Jacek Majewski; Andrey Korshunov; Peter Lichter; Christoph Plass; Nada Jabado; Stefan M Pfister
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

Review 8.  Epidermal growth factor receptor: a re-emerging target in glioblastoma.

Authors:  Monika E Hegi; Premnath Rajakannu; Michael Weller
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

9.  EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

Authors:  C A Del Vecchio; C P Giacomini; H Vogel; K C Jensen; T Florio; A Merlo; J R Pollack; A J Wong
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

10.  Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.

Authors:  Edward R Kastenhuber; Jason T Huse; Samuel H Berman; Alicia Pedraza; Jianan Zhang; Yoshiyuki Suehara; Agnes Viale; Magali Cavatore; Adriana Heguy; Nicholas Szerlip; Marc Ladanyi; Cameron W Brennan
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

View more
  3 in total

1.  In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The φ-Index.

Authors:  Spyridon Bakas; Hamed Akbari; Jared Pisapia; Maria Martinez-Lage; Martin Rozycki; Saima Rathore; Nadia Dahmane; Donald M O'Rourke; Christos Davatzikos
Journal:  Clin Cancer Res       Date:  2017-04-20       Impact factor: 12.531

Review 2.  Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.

Authors:  Anahita Fathi Kazerooni; Spyridon Bakas; Hamidreza Saligheh Rad; Christos Davatzikos
Journal:  J Magn Reson Imaging       Date:  2019-08-27       Impact factor: 4.813

3.  Multiomics profiling of paired primary and recurrent glioblastoma patient tissues.

Authors:  Lennard J M Dekker; Nynke M Kannegieter; Femke Haerkens; Emma Toth; Johan M Kros; Dag Are Steenhoff Hov; Julien Fillebeen; Lars Verschuren; Sieger Leenstra; Anna Ressa; Theo M Luider
Journal:  Neurooncol Adv       Date:  2020-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.